Vecuronium Bromide interactions
Checked as Vecuronium in this data source.
Full monograph for Vecuronium BromideCheck it against another medicine
Medicines
282 documented
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| Amikacin | Major | Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially… | 17 sources — open the full entry |
| Bacitracin Zinc + Polymyxin B Sulfate | Major | Others · Synergy | Polymyxin B may prolong apnea and respiratory paralysis after use of neuromuscular blocking agents. The mechanism may be related to decreased intracellular…2 documented mechanisms | 5 sources — open the full entry |
| Betamethasone + Clotrimazole + Gentamicin | Major | Others · Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially…2 documented mechanisms | 24 sources — open the full entry |
| Betamethasone + Neomycin Sulphate (Ophthalmic) | Major | Others · Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially…2 documented mechanisms | 24 sources — open the full entry |
| Cinchocaine + Hydrocortisone + Framycetin + Esculin | Major | Others · Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially…2 documented mechanisms | 24 sources — open the full entry |
| Cinchocaine + Hydrocortisone + Neomycin + Esculin | Major | Others · Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially…2 documented mechanisms | 24 sources — open the full entry |
| Clobetasol Propionate + Neomycin Sulphate + Nystatin | Major | Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially… | 17 sources — open the full entry |
| Colistimethate Sodium | Major | Synergy | Like other polypeptide antibiotics, colistimethate may prolong apnea and respiratory paralysis after use of neuromuscular blocking agents. The mechanism may be… | 10 sources — open the full entry |
| Dexamethasone + Neomycin + Glacial Acetic Acid | Major | Others · Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially…2 documented mechanisms | 24 sources — open the full entry |
| Dexamethasone + Neomycin Sulphate + Polymyxin B Sulphate | Major | Others · Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially…3 documented mechanisms | 27 sources — open the full entry |
| Dexamethasone + Tobramycin | Major | Others · Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially…2 documented mechanisms | 24 sources — open the full entry |
| Fluocinolone Acetonide + Neomycin Sulfate | Major | Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially… | 17 sources — open the full entry |
| Fluormetholone + Neomycin Sulphate | Major | Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially… | 17 sources — open the full entry |
| Fluorometholone + Gentamicin | Major | Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially… | 17 sources — open the full entry |
| Gentamicin + Hydrocortisone Acetate | Major | Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially… | 17 sources — open the full entry |
| Gentamicin SulfateInjectionOphthalmic | Major | Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially… | 17 sources — open the full entry |
| Gramacidin + Neomycin + Polymixin B | Major | Others · Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially…2 documented mechanisms | 20 sources — open the full entry |
| Hydrocortisone + Neomycin Sulphate + Polymixin B | Major | Others · Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially…3 documented mechanisms | 27 sources — open the full entry |
| Hydrocortisone Acetate + Neomycin Sulphate | Major | Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially… | 17 sources — open the full entry |
| Kanamycin | Major | Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially… | 17 sources — open the full entry |
| Loteprednol Etabonate + Tobramycin | Major | Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially… | 17 sources — open the full entry |
| Metronidazole + Neomycin Sulphate + Polymyxin B + Nystatin | Major | Others · Synergy · Unknown | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially…3 documented mechanisms | 20 sources — open the full entry |
| Neomycin Sulfate + Bacitracin Zinc | Major | Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially…2 documented mechanisms | 19 sources — open the full entry |
| Neomycin Sulfate + Bacitracin Zinc + Polymyxin B Sulfate | Major | Others · Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially…3 documented mechanisms | 22 sources — open the full entry |
| Neomycin Sulphate + Polymyxin B Sulphate + Pramoxine | Major | Others · Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially…2 documented mechanisms | 20 sources — open the full entry |
| Oxytetracycline + Polymixin B Sulphate | Major | Others · Synergy | Polymyxin B may prolong apnea and respiratory paralysis after use of neuromuscular blocking agents. The mechanism may be related to decreased intracellular…2 documented mechanisms | 5 sources — open the full entry |
| Polymyxin B Sulfate | Major | Others | Polymyxin B may prolong apnea and respiratory paralysis after use of neuromuscular blocking agents. The mechanism may be related to decreased intracellular… | 3 sources — open the full entry |
| Prednisolone + Neomycin Sulphate + Polymixin B Sulphate | Major | Others · Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially…3 documented mechanisms | 27 sources — open the full entry |
| TobramycinNebuliser SolutionOphthalmic | Major | Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially… | 17 sources — open the full entry |
| Triamcinolone + Neomycin + Nystatin + Gramicidin | Major | Others · Synergy | Aminoglycosides possess neuromuscular blocking activity, which may be additive with that of depolarizing and nondepolarizing muscle relaxants, potentially…2 documented mechanisms | 24 sources — open the full entry |
| Acetazolamide | Moderate | Synergy | Diuretics may induce hypokalemia and prolong the neuromuscular blocking effects of nondepolarizing muscle relaxants. | 4 sources — open the full entry |
| Acyclovir + Hydrocortisone | Moderate | Others · Unknown | Corticosteroids may inhibit or enhance the action of nondepolarizing skeletal muscle relaxants. The mechanism is unknown. In addition, the risk of myopathy may…2 documented mechanisms | 7 sources — open the full entry |
| Alprazolam | Moderate | Others | Benzodiazepines may have variable effects on nondepolarizing muscle relaxants. Potentiation, attenuation, and no effect have all been reported. | 9 sources — open the full entry |
| Aminophylline | Moderate | Antagonism | Methylxanthines may antagonize the effects of neuromuscular blockers. The mechanism is unknown. In patients stabilized on aminophylline, resistance to… | 3 sources — open the full entry |
| Amitriptyline Hydrochloride + Chlordiazepoxide | Moderate | Others | Benzodiazepines may have variable effects on nondepolarizing muscle relaxants. Potentiation, attenuation, and no effect have all been reported. | 9 sources — open the full entry |
| Amlodipine Besilate | Moderate | Synergy | Some calcium channel blockers may enhance the neuromuscular blocking properties of nondepolarizing muscle relaxants. The mechanism is not known, but may… | 36 sources — open the full entry |
| Amlodipine Besilate + Atenolol | Moderate | Synergy | Some calcium channel blockers may enhance the neuromuscular blocking properties of nondepolarizing muscle relaxants. The mechanism is not known, but may…2 documented mechanisms | 44 sources — open the full entry |
| Amlodipine Besilate + Atorvastatin | Moderate | Synergy | Some calcium channel blockers may enhance the neuromuscular blocking properties of nondepolarizing muscle relaxants. The mechanism is not known, but may… | 36 sources — open the full entry |
| Amlodipine Besilate + Benazepril Hydrochloride | Moderate | Synergy | Some calcium channel blockers may enhance the neuromuscular blocking properties of nondepolarizing muscle relaxants. The mechanism is not known, but may… | 36 sources — open the full entry |
| Amlodipine Besilate + Olmesartan Medoxomil | Moderate | Synergy | Some calcium channel blockers may enhance the neuromuscular blocking properties of nondepolarizing muscle relaxants. The mechanism is not known, but may… | 36 sources — open the full entry |
| Amlodipine Besilate + Telmisartan | Moderate | Synergy | Some calcium channel blockers may enhance the neuromuscular blocking properties of nondepolarizing muscle relaxants. The mechanism is not known, but may… | 36 sources — open the full entry |
| Amlodipine Besilate + Valsartan | Moderate | Synergy · Unknown | Some calcium channel blockers may enhance the neuromuscular blocking properties of nondepolarizing muscle relaxants. The mechanism is not known, but may…2 documented mechanisms | 36 sources — open the full entry |
| Amphotericin B | Moderate | Excretion | Amphotericin commonly causes renal potassium and magnesium wasting. As a result, serum potassium is decreased, and the pharmacologic effects of some… | 4 sources — open the full entry |
| Atenolol | Moderate | Synergy | Neuromuscular blocking agents and beta-blockers may have additive cardiovascular depressant effects. Limited data suggest that beta-blockers may modestly… | 8 sources — open the full entry |
| Atenolol + Chlorthalidone | Moderate | Synergy | Neuromuscular blocking agents and beta-blockers may have additive cardiovascular depressant effects. Limited data suggest that beta-blockers may modestly…2 documented mechanisms | 12 sources — open the full entry |
| Atracurium Besilate | Moderate | Synergy | When combined with vecuronium, other nondepolarizing neuromuscular blocking agents may have additive effects or modifying influences. | 3 sources — open the full entry |
| Azilsartan Medoxomil + Chlorthalidone | Moderate | Synergy | Diuretics may induce hypokalemia and prolong the neuromuscular blocking effects of nondepolarizing muscle relaxants. | 4 sources — open the full entry |
| Beclomethasone Dipropionate + Chloramphenicol + Clotrimazole + Lidocaine | Moderate | Synergy | Lidocaine may enhance the effect of neuromuscular blocking agents. The mechanism is not known, but may include inhibition of acetylcholine release from… | 6 sources — open the full entry |
| Betamethasone | Moderate | Others | Corticosteroids may inhibit or enhance the action of nondepolarizing skeletal muscle relaxants. The mechanism is unknown. In addition, the risk of myopathy may… | 7 sources — open the full entry |
| Betamethasone + Calcipotriol | Moderate | Others | Corticosteroids may inhibit or enhance the action of nondepolarizing skeletal muscle relaxants. The mechanism is unknown. In addition, the risk of myopathy may… | 7 sources — open the full entry |
Conditions
Conditions in which Vecuronium Bromide needs care, as documented in this source.
Liver Diseases
MajorNeuromuscular blocking agents undergo metabolism by the liver. Elimination and effects may be prolonged in patients with liver disease. Therapy with neuromuscular blocking agents should be administered cautiously in patients with liver disease.
5 sources
- "Product Information. Zemuron (rocuronium)." Organon (2001):
- "Product Information. Mivacron (mivacurium)." Glaxo Wellcome (2001):
- "Product Information. Nuromax (doxacurium)." Glaxo Wellcome (2001):
- "Product Information. Norcuron (vecuronium)." Organon (2001):
- "Product Information. Metubine Iodide (metocurine)." Dista Products Company (2001):
Paresis
MajorPatients with hemiparesis or paraparesis may require higher dosages of non-depolarizing neuromuscular blocking agents in the affected limbs. Neuromuscular monitoring should be performed on a non-paretic limb to avoid inaccurate dosing.
6 sources
- "Product Information. Zemuron (rocuronium)." Organon (2001):
- "Product Information. Mivacron (mivacurium)." Glaxo Wellcome (2001):
- "Product Information. Nuromax (doxacurium)." Glaxo Wellcome (2001):
- "Product Information. Tracrium (atracurium)." Glaxo Wellcome (2001):
- "Product Information. Norcuron (vecuronium)." Organon (2001):
- "Product Information. Metubine Iodide (metocurine)." Dista Products Company (2001):
Respiratory Insufficiency
MajorNeuromuscular blocking agents can cause respiratory depression and paralysis. Therapy with neuromuscular blocking agents should be administered cautiously in patients with pulmonary impairment. Treatment of respiratory paralysis consists of positive-pressure artificial respiration with oxygen and maintenance of a patent airway until the recovery of normal respiration is assured.
7 sources
- "Product Information. Zemuron (rocuronium)." Organon (2001):
- "Product Information. Anectine (succinylcholine)." Glaxo Wellcome (2001):
- "Product Information. Mivacron (mivacurium)." Glaxo Wellcome (2001):
- "Product Information. Nuromax (doxacurium)." Glaxo Wellcome (2001):
- "Product Information. Tracrium (atracurium)." Glaxo Wellcome (2001):
- "Product Information. Norcuron (vecuronium)." Organon (2001):
- "Product Information. Metubine Iodide (metocurine)." Dista Products Company (2001):